Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 794. The contact email is not on this page.
- PREVENTION STRATEGIES, LLC
NIH R43: A Gamified Approach to Adolescent Alcohol Prevention that Strengthens Social Skills and Personal Values
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VON Medical, Inc.
Form D history: Other
startup · FL · amount not stated · 2022-09-14
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-09-14.
- DEGROME THERAPEUTICS, INC.
NIH R41: Development of Small-Molecule Degraders of APP as the first-in-class drugs for Alzheimer's therapy
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DAIGNOSTX L.L.C.
NIH R41: System for Malignant Lymph Node Identification
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VAXNEWMO, LLC
NIH R42: A multivalent O-antigen bioconjugate vaccine for the prevention of Klebsiella pneumoniae infections
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- REWIRE NEUROSCIENCE, LLC
NIH R41: Development and in vivo validation of a machine learning platform to predict ototoxic potential of pharmaceuticals
startup · OR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANALYTICAL DIAGNOSTIC SOLUTIONS, INC.
NIH R44: A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PolyVascular, Inc.
Form D history: Other Health Care
startup · TX · amount not stated · 2023-07-18
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-07-18.
- OMEGAQUANT ANALYTICS, LLC
NIH R41: Developing blood fatty acid-based algorithms as early predictors of macular degeneration and glaucoma: Applying machine learning to harmonized data from prospective cohort studies
startup · SD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MIROFEND LLC
NIH R41: A NEW TREATMENT APPROACH FOR LETHAL DRUG-RESISTANT BACTERIAL SKIN INFECTIONS
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EPIGENOME TECHNOLOGIES, INC.
NIH R44: High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PULMERA, INC.
NIH R44: Advanced 3D Imaging to Aid in Peripheral Lung Nodule Diagnosis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Cell Microsystems, Inc.
Form D history: Biotechnology
startup · NC · amount not stated · 2023-08-28
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-08-28.
- LIGHT SWITCH BIO, LLC
NIH R41: Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic.
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SURVEY GENOMICS, INC.
NIH R44: Pioneering assays for spatially-resolved single-cell multiomics
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- QUIVER BIOSCIENCE INC.
NIH R44: Functional drug fingerprinting with all-optical electrophysiology
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GRYPHON BIO, INC.
NIH R44: Development of Novel sgp130-Fc Bioconjugates for TBI
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HEALTH DISCOVERY LABS LLC
NIH R44: Closed Loop Electrical Muscle Stimulation System (CL-EMS) with improved safety for ICU environment to mitigate ICU Acquired Weakness
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BLUEGRASS ADVANCED MATERIALS, LLC
NIH R44: Development of Smart Flocculants for the Treatment of PFAS Contaminated Water
startup · KY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INFORMAI, INC.
NIH R44: Artificial Intelligence Tool to Optimize Organ Transplantation Outcomes (Transplant-AI)
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVANCED MEDICAL ELECTRONICS CORPORATION
NIH R44: A Mobile Informatics Solution to Assist Caregivers with Care Coordination and Social Engagement
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ZVELT THERAPEUTICS INC.
NIH R42: Novel Adipose Targeted Gene Therapy for Lipodystrophy
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- COMETA THERAPEUTICS INC
NIH R42: ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENGAGE BIOLOGICS INC.
NIH R44: Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOSURFACES
NIH R44: Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MODULATION THERAPEUTICS, INC.
NIH R44: Modulation of cancer induced immune suppression via inhibition of SCD1
startup · WV · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- XANTHOSHEALTH, INC.
NIH R42: ConnectedNest: a digital platform connecting individuals with cancer to social care
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CAPTIS DIAGNOSTICS
NIH R44: Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- REAL PREVENTION, LLC
NIH R44: Developing and testing the Opioid Rapid Response System
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SAGESPECTRA INC.
NIH R43: Development and validation of a wireless patch for post-surgical monitoring and electrotherapy of surgical flaps
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SENESCOPE, INC.
NIH R43: A novel AI platform to detect cellular senescence and measure biological age using biofluids
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FIBRONOX, L.L.C.
NIH R41: Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary Fibrosis
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GROUPWARE TECHNOLOGIES, LLC
NIH R44: A unified eligibility application and determination system to increase Ryan White linkage to care and retention in care by reducing structural barriers and facilitating client engagement
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VIVOVERSE, LLC
NIH R44: The Next-Generation Developmental and Reproductive Toxicology (DART) Assay using High-Content Analysis of Genetically Diverse C. elegans Populations
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SIMPLUSDX, INC.
NIH R43: A rapid point-of-care test for therapeutic drug monitoring of tacrolimus
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FLIK THERAPEUTICS, INC.
NIH R43: Development of a novel therapeutic platform for smoking cessation and nicotine de-addiction
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ORPRO THERAPEUTICS, INC.
NIH R41: Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HALOMINE, INC.
NIH R43: Novel, bio-inspired chloramine for infection eradication in chronic wounds
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- March Biosciences
startup · TX · amount not stated · 2024-10-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-10-22.
- METAMEDIA TRAINING INTERNATIONAL, INC.
NIH R43: Immersive Escape Room Gamification: Transportation Hazmat Incident (iERG)
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.